Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar-Apr;2(2):190-8.
doi: 10.4161/mabs.2.2.11220.

Neutralization of Clostridium difficile toxin A using antibody combinations

Affiliations

Neutralization of Clostridium difficile toxin A using antibody combinations

Stephen J Demarest et al. MAbs. 2010 Mar-Apr.

Abstract

The pathogenicity of Clostridium difficile (C. difficile) is mediated by the release of two toxins, A and B. Both toxins contain large clusters of repeats known as cell wall binding (CWB) domains responsible for binding epithelial cell surfaces. Several murine monoclonal antibodies were generated against the CWB domain of toxin A and screened for their ability to neutralize the toxin individually and in combination. Three antibodies capable of neutralizing toxin A all recognized multiple sites on toxin A, suggesting that the extent of surface coverage may contribute to neutralization. Combination of two noncompeting antibodies, denoted 3358 and 3359, enhanced toxin A neutralization over saturating levels of single antibodies. Antibody 3358 increased the level of detectable CWB domain on the surface of cells, while 3359 inhibited CWB domain cell surface association. These results suggest that antibody combinations that cover a broader epitope space on the CWB repeat domains of toxin A (and potentially toxin B) and utilize multiple mechanisms to reduce toxin internalization may provide enhanced protection against C. difficile-associated diarrhea.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis of the neutralization capability of 3359 and 3358 combinations following a co-incubation with 80 ng (0.8 µg/mL) toxin A on CHO cell surfaces. (A) Titration of 3359 in the presence of 0, 0.5, 1 and 2 µg 3358. (B) Titration of 3358 in the presence of 0, 0.5, 1 and 2 µg 3359. The combination of the two antibodies (2 µg 3358 + 2 µg 3359) was significantly more neutralizing than 4 mg of 3358 or 4 mg of 3359 (p = 0.03 and p = 0.01, respectively).
Figure 2
Figure 2
Images from culture plates 48 h after seeding with CHO-K1 cells in the absence (A) and presence of toxin A (B). As a positive neutralization control, an anti-C. difficile toxin polyclonal antibody mixture (TE CHLAB®) was added to the medium with toxin A (F). mAbs 3358 (C) and 3359 (D) were added separately and together (E) with toxin A to the culture media. Addition of 20 ng (0.2 mg/mL) toxin A to the CHO cell media led to >90% cell rounding following 2 days of incubation.
Figure 3
Figure 3
Antibody competition for ToxA:40R binding studied by surface plasmon resonance. Solutions containing 15 nM ToxA:40R were injected over surfaces containing immobilized rPCG-4 (circles), 3359 (triangles) or 3358 (squares). ToxA:40R was titrated with (A) rPCG-4 Fab, (B) rPCG-4 antibody, (C) 3359 or (D) 3358.
Figure 4
Figure 4
CHO cell surface binding of ToxA:11R in the presence and absence of anti-toxin A antibodies as determined by flow cytometry. Fluorescence of the CHO cell population (A) in the absence of ToxA:11R; (B) in the presence of 50 µg/mL ToxA:11R alone; and in the presence of (C) 250 µg/mL 3358, (D) 250 µg/mL 3359, (E) 250 µg/mL rPCG-4, (F) 250 µg/mL 3358 and 250 µg/mL 3359, (G) 250 µg/mL 3359 and 250 µg/mL rPCG-4 or (H) 250 µg/mL 3358 and 250 µg/mL rPCG-4.

Similar articles

Cited by

References

    1. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol Clin North Am. 2001;30:753–777. - PubMed
    1. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea. Arch Int Med. 2001;161:525–533. - PubMed
    1. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: Its disease and toxins. Clin Microbiol Rev. 1988;1:1–18. - PMC - PubMed
    1. Pothoulakis C, LaMont JT. Microbes and microbial toxins: paradigms for microbial mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol. 2001;280:178–183. - PubMed
    1. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North Americ and Europe. Clin Microbiol Infect. 2008;12:2–18. - PubMed

MeSH terms